中国药业2017，Vol.26Issue(16)：38-40,3.DOI:10.3969/j.issn.1006-4931.2017.16.012
白塞补泻颗粒治疗白塞病20例临床评价
Clinical Evaluation of Baisai Buxie Granule for Treating Behcet's Disease in 20 Cases
摘要
Abstract
Objective To investigate the clinical effect of Baisai Buxie Granule in treating Behcet's disease(BD). Methods Totally 40 patients with BD in our hospital were selected and randomly divided into the experimental group and the control group,20 cases in each group. The control group was treated with conventional western medicine(thalidomide)and the experimental group was treated with Baisai Buxie Granule. Results The total effective rate of the experimental group was 90. 00% ,which was significantly higher than 75. 00% of the control group( P< 0. 05). After treatment,the scores of bitter taste,eye diseases,fatigue and oral ulcer,the levels of CRP and ESR in the experimental group were significantly lower than those in the control group( P< 0. 05). The incidence rates of adverse reactions in the experimental group and the control group were 15. 00% and 10. 00% without significant difference ( P > 0. 05). The recurrence rate of the experimental group was 15. 00%,which was significantly lower than 45. 00% of the control group( P < 0. 05). Conclusion Baisai Buxie Granule in treating BD is beneficial to promote the improvement of clinical symptoms,reduce the inflammatory reaction and the ESR. It is worthy of clinical promotion.关键词
白塞病/白塞补泻颗粒/C反应蛋白/临床疗效Key words
Behcet's disease/Baisai Buxie Granule/C reactive protein/clinical effect分类
医药卫生引用本文复制引用
石海军,尹国富,刘福华,岳敏..白塞补泻颗粒治疗白塞病20例临床评价[J].中国药业,2017,26(16):38-40,3.基金项目
山东省潍坊市中医药科研计划项目[2013-020]. （）
